Preparation, statistical optimisation and in vitro characterisation of poly (3-hydroxybutyrate-co-3-hydroxyvalerate)/poly (lactic-co-glycolic acid) blend nanoparticles for prolonged delivery of teriparatide

References

• Alex R, Bodmeier R. Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment. J Microencapsul, 1990;7:347–55.
   PubMed Web of Science ®Google Scholar
• Allison S. Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv, 2008;5:615–28.
   PubMed Web of Science ®Google Scholar
• Alzubaidi AF, El-Helw AM, Ahmed TA, Ahmed OA. The use of experimental design in the optimization of risperidone biodegradable nanoparticles: in vitro and in vivo study. Artif Cells Nanomed Biotechnol, 2016. doi:10.3109/21691401.2016.1147453.
   PubMedGoogle Scholar
• Amasya G, Badilli U, Aksu B, Tarimci N. Quality by design case study 1: Design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion—Solvent evaporation method. Eur J PharmSci, 2016;84:92–102.
   PubMed Web of Science ®Google Scholar
• Asghar S, Salmani JM, Hassan W, Xie Y, Meng F, Su Z, Sun M, Xiao Y, Ping Q. A facile approach for crosslinker free nanoself assembly of protein for anti-tumor drug delivery: Factors' optimization, characterization and in vitro evaluation. Eur J Pharm Sci, 2014;63:53–62.
   PubMed Web of Science ®Google Scholar
• Baş D, Boyaci İH. Modeling and optimization I: Usability of response surface methodology. J Food Eng, 2007;78:836–45.
   Web of Science ®Google Scholar
• Bazzo GC, Macedo ATD, Crenca JP, Silva VE, Pereira EM, Zétola M, Pezzini BR. Microspheres prepared with biodegradable PHBV and PLA polymers as prolonged-release system for ibuprofen: In vitro drug release and in vivo evaluation. Brazil J Pharm Sci, 2012;48:773–80.
   Web of Science ®Google Scholar
• Bezerra MA, Santelli RE, Oliveira EP, Villar LS, Escaleira LA. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta, 2008;76:965–77.
   PubMed Web of Science ®Google Scholar
• Box G, Behnken D. Some new three level designs for the study of quantitative variables. Technometrics, 1960;2:455–75.
   Google Scholar
• Brown L. Commercial challenges of protein drug delivery. Expert Opin Drug Deliv, 2005;2:29–42.
   PubMedGoogle Scholar
• Capelle M, Gurny R, Arvinte T. High throughput screening of protein formulation stability: Practical considerations. Eur J Pharm Biopharm, 2007;65:131–48.
   PubMed Web of Science ®Google Scholar
• Chatterjee K, Sarkar S, Rao KJ, Paria S. Core/shell nanoparticles in biomedical applications. Adv Colloid Interface Sci, 2014;209:8–39.
   PubMed Web of Science ®Google Scholar
• Csaba N, Caamano P, Sanchez A, Dominguez F, Alonso MJ. PLGA: Poloxamer and PLGA: Poloxamineblend nanoparticles: New carriers for gene delivery. Biomacromolecules, 2005;6:271–8.
   PubMed Web of Science ®Google Scholar
• Csaba N, Sánchez A, Alonso MJ. PLGA: Poloxamer and PLGA: Poloxamine blend nanostructures as carriers for nasal gene delivery. J Controll Release, 2006;113:164–72.
   PubMed Web of Science ®Google Scholar
• Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Preat V. PLGA-based nanoparticles: An overview of biomedical applications. J Control Release, 2012;161:505–22.
   PubMed Web of Science ®Google Scholar
• Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Poloniae Pharm Drug Res, 2010;67:217–23.
   PubMed Web of Science ®Google Scholar
• Dizaj SM, Lotfipour F, Barzegar-Jalali M, Zarrintan MH, Adibkia K. Box-Behnken experimental design for preparation and optimization of ciprofloxacin hydrochloride-loaded CaCO3 nanoparticles. J Drug Deliv Sci Technol, 2015;29:125–31.
   Web of Science ®Google Scholar
• El-Leithy ES, Shaker DS, Ghorab MK, Abdel-Rashid RS. Optimization and characterization of diclofenac sodium microspheres prepared by a modified coacervation method. Drug Discov Ther, 2010;4:208–16.
   PubMedGoogle Scholar
• Emilio Mendes JB, Riekes MKU, Oliveira VD, Michel MD, Stulzer HK, Khalil N, Zawadzki SOF, Rubianamaramainardes Farago PV. PHBV/PCL Microparticles for controlled release of resveratrol: Physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes. Sci World J, 2012;2012:1–13.
   Web of Science ®Google Scholar
• Estrada LH, Chu S, Champion JA. Protein nanoparticles for intracellular delivery of therapeutic enzymes. J Pharm Sci, 2014;103:1863–71.
   PubMed Web of Science ®Google Scholar
• Eswaramoorthy R, Chang CC, Wu SC, Wang GJ, Chang JK, Ho ML. Sustained release of PTH(1-34) from PLGA microspheres suppresses osteoarthritis progression in rats. Acta Biomater, 2012;8:2254–62.
   PubMed Web of Science ®Google Scholar
• Feczkó T, Tóth J, Dósa G, Gyenis J. Optimization of protein encapsulation in PLGA nanoparticles. Chem Eng Process, 2011;50:757–65.
   Web of Science ®Google Scholar
• Feng SS, Huang G . Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers. J Control Release, 2001;71:53–69.
   PubMed Web of Science ®Google Scholar
• Ferreira SLC, Bruns RE, Ferreira HS, Matos GD, David JM, Brandão GC, Silva EGPD, Portugal LA, Reis PSD, Souza AS, Santos WNLD. Box-Behnken design: An alternative for the optimization of analytical methods. Analytica Chimica Acta, 2007;597:179–86.
   PubMed Web of Science ®Google Scholar
• Fogueri L, Singh S. Smart polymers for controlled delivery of proteins and peptides: A review of patents. Recent Pat Drug Deliv Formul, 2009;3:40–8.
   PubMedGoogle Scholar
• Fukada E, Ando Y. Piezoelectric properties of poly b-hydroxybutyrate and copolymers of b-hydroxybutyrate and b-hydroxyvalerate. Int J Biol Macromol, 1986;8:361–6.
   Web of Science ®Google Scholar
• Gaignaux A, Reeff J, Siepmann F, Siepmann J, De Vriese C, Goole J, Amighi K. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. Int J Pharm, 2012;437:20–8.
   PubMed Web of Science ®Google Scholar
• Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier: Systematic examination of fabrication conditions for efficient loading and release. Colloids Surf B: Biointerfaces, 2007;59:24–34.
   PubMed Web of Science ®Google Scholar
• Ganti V, Mengesha AE, Marszalek J, Youan BBC. Statistical analysis of low molecular mass heparin nanoencapsulation. Acta Pharm, 2010;60:281–93.
   PubMed Web of Science ®Google Scholar
• Geng Y, Yuan W, Wu F, Chen J, He M, Jin T. Formulating erythropoietin-loaded sustained-release PLGA microspheres without protein aggregation. J Control Release, 2008;130:259–65.
   PubMed Web of Science ®Google Scholar
• Ghasemian E, Vatanara A, Najafabadi AR, Rouini MR, Gilani K, Darabi M. Preparation, characterization and optimization of sildenafil citrate loaded PLGA nanoparticles by statistical factorial design. DARU J PharmSci, 2013;21:68–77.
   PubMed Web of Science ®Google Scholar
• Grassi M, Grassi G. Mathematical modelling and controlled drug delivery: Matrix systems. Curr Drug Deliv, 2005;2:97–116.
   PubMedGoogle Scholar
• Guhagarkar S, Malshe V, Devarajan P. Nanoparticles of polyethylene sebacate: A new biodegradable polymer. AAPS Pharm Sci Tech, 2009;10:935–42.
   PubMed Web of Science ®Google Scholar
• Halder S, Hasan M, Das BK, Kabir AKL, Rouf ASS. Release study of carvedilol phosphate matrix tablets prepared with hydroxypropyl methylcellulose. Tropical J Pharm Res, 2012;11:379–86.
   Web of Science ®Google Scholar
• Hussein AS, Abdullah N, Fakru'l-Razi A. Optimizing the process parameters for encapsulation of linamarin into PLGA nanoparticles using double emulsion solvent evaporation technique. Adv Polymer Technol, 2013;32:E486–504.
   Web of Science ®Google Scholar
• Jayamanti P, Yasmin S, Mohd A. Poly(lactide-co-glycolide) nanoparticles for an extended delivery of bevacizumab to retina: Formulation and in vitro characterization. Adv Sci Lett, 2014;20:1588–93.
   Google Scholar
• Koopaei MN, Khoshayand MR, Mostafavi SH, Amini M, Khorramizadeh MR, Tehrani MJ, Atyabi F, Dinarvand R. Docetaxel loaded PEG-PLGA nanoparticles: Optimized drug loading, in-vitro cytotoxicity and in-vivo antitumor effect. Iran J Pharm Res, 2014;13:819–33.
   PubMed Web of Science ®Google Scholar
• Koosha F, Muller R, Davis S. Polyhydroxybutyrate as a drug carrier. Crit Rev Ther Drug Carrier Syst, 1989;6:117–30.
   PubMed Web of Science ®Google Scholar
• Kose G, Korkusuz F, Ozkul A, Soysal Y, Ozdemir T, Yildiz C, Hasirci V. Tissue engineered cartilage on collagen and PHBV matrices. Biomaterials, 2005;26:5187–97.
   PubMed Web of Science ®Google Scholar
• Kumar A, Ahuja M. Carboxymethyl gum kondagogu–chitosan polyelectrolyte complex nanoparticles: Preparation and characterization. Int J Biol Macromol, 2013;62:80–4.
   PubMed Web of Science ®Google Scholar
• Kumar T, Soppimath K, Nachaegari S. Novel delivery technologies for protein and peptide therapeutics. Curr Pharm Biotechnol, 2006;7:261–76.
   PubMed Web of Science ®Google Scholar
• Kwon HY, Lee JY, Choi SW, Jang Y, Kim JH. Preparation of PLGA nanoparticles containing estrogen by emulsification–diffusion method. Colloids Surf A: Physicochem Eng Aspects, 2001;182:123–30.
   Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Pérez MH, Lehr C, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm, 2000;196:177–82.
   PubMed Web of Science ®Google Scholar
• Lao LL, Peppas NA, Boey FYC, Venkatraman SS. Modeling of drug release from bulk-degrading polymers. Int J Pharm, 2011;418:28–41.
   PubMed Web of Science ®Google Scholar
• Lohcharoenkal W, Wang L, Chen YC, Rojanasakul Y. Protein nanoparticles as drug delivery carriers for cancer therapy. Biomed Res Int, 2014;2014:1–12.
   Web of Science ®Google Scholar
• Lu X, Gao H, Li C, Yang YW, Wang Y, Fan Y, Wu G, Ma J. Polyelectrolyte complex nanoparticles of amino poly(glycerol methacrylate)s and insulin. Int J Pharm, 2012;423:195–201.
   PubMed Web of Science ®Google Scholar
• Mahboubian A, Hashemein S, Moghadam S, Atyabi F, Dinarvand R. Preparation and in-vitro evaluation of controlled release PLGA microparticles containing triptoreline. Iran J Pharm Res, 2010;9:369–78.
   PubMed Web of Science ®Google Scholar
• Malik D, Baboota S, Ahuja A, Hasan S, Ali J. Recent advances in protein and peptide drug delivery systems. Curr Drug Deliv, 2007;4:141–51.
   PubMedGoogle Scholar
• Mao S, Xu J, Cai C, Germershaus O, Schaper A, Kissel T. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm, 2007;334:137–48.
   PubMed Web of Science ®Google Scholar
• Marucci M, Ragnarsson G, Nyman U, Axelsson A. Mechanistic model for drug release during the lag phase from pellets coated with a semi-permeable membrane. J Controll Release, 2008;127:31–40.
   PubMed Web of Science ®Google Scholar
• Mohanty A, Misra M, Drzal L. 2005. Natural fibers, biopolymers and biocomposites. Boca Raton, FL: CRC Press Publishing Company, Taylor & Francis Group.
   Google Scholar
• Parajo Y, D'angelo I, Horvath A, Vantus T, Gyorgy K, Welle A, Garcia-Fuentes M, Alonso MJ. PLGA: Poloxamer blend micro- and nanoparticles as controlled release systems for synthetic proangiogenic factors. Eur J Pharm Sci, 2010;41:644–9.
   PubMed Web of Science ®Google Scholar
• Pekarek KJ, Jacob JS, Mathiowitz E. Double-walled polymer microspheres for controlled drug-release. Nature, 1994;367:258–60.
   PubMed Web of Science ®Google Scholar
• Peng Q, Zhang ZR, Gong T, Chen GQ, Sun X. A rapid-acting, long-acting insulin formulation based on a phospholipid complex loaded PHBHHx nanoparticles. Biomaterials, 2012;33:1583–8.
   PubMed Web of Science ®Google Scholar
• Pouton C, Akhtar S. Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Advdrug del Rev, 1996;18:133–62.
   Web of Science ®Google Scholar
• Q2B, C. 1996. Validation of analytical procedures: Methodology, International Conferenceon Harmonization (ICH) of Technical Requirements for the registration of Pharmaceuticals for Human Use, Guidance for Industry, 1–13.
   Google Scholar
• Qiao M, Chen D, Hao T, Zhao X, Hu H, Ma X. Effect of bee venom peptide-copolymer interactions on thermosensitive hydrogel delivery systems. Int J Pharm, 2007;345:116–24.
   PubMed Web of Science ®Google Scholar
• Quattrocchi E, Kourlas H. Teriparatide: A review. Clin Therapeutics, 2004;26:841–54.
   PubMed Web of Science ®Google Scholar
• Rahman NA, Mathiowitz E. Localization of bovine serum albumin in double-walled microspheres. J Control Release, 2004;94:163–75.
   PubMed Web of Science ®Google Scholar
• Ramazani F, Chen W, Nostrum CFV, Storm G, Kiessling F, Lammers T, Hennink WE, Kok RJ, Formulation and characterization of microspheres loaded with imatinib for sustained delivery. Int J Pharm, 2015;482:123–30.
   PubMed Web of Science ®Google Scholar
• Rezaie Shirmard L, Bahari Javan N, Khoshayand MR, Kebriaee-zadeh A, Dinarvand R, Dorkoosh FA. Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): Design, optimization, characterization and in-vitro evaluation. Pharmaceut Develop Technol, 2015. doi:10.3109/10837450.2015.1108982.
   PubMedGoogle Scholar
• Rizkalla NV, Hildgen P. Artificial neural networks: Comparison of two programs for modeling a process of nanoparticle preparation. Drug Develop Indus Pharm, 2005;31:1019–33.
   PubMed Web of Science ®Google Scholar
• Rosa GD, Iommelli R, Rotonda MIL, Miro A, Quaglia F. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J Control Release, 2000;69:283–95.
   PubMed Web of Science ®Google Scholar
• Rane SS, Ajameri A, Mody R, Padmaja P. Development and validation of RP-HPLC and RP-UPLC methods forquantification of parathyroid hormones (1-34) in medicinal product formulated with meta-cresol. J Pharmaceut Anal, 2012;2:136–42.
   Google Scholar
• Saadat E, Abdollahi A, Dorkoosh FA. Fabrication and characterization of risperidone implants as an extended antipsychotic delivery system, exploring the role of excipients. J Pharm Innov, 2015;10:118–29.
   Web of Science ®Google Scholar
• Sahana DK, Mittal G, Bhardwaj V, Kumar MNVR. PLGA nanoparticles for oral delivery of hydrophobic drugs: Influence of organic solvent on nanoparticle formation and release behavior in vitro and in vivo using estradiol as a model drug. J Pharmaceut Sci, 2008;97:1530–42.
   PubMed Web of Science ®Google Scholar
• Santander-Ortega MJ, Csaba N, Alonso MJ, Ortega-Vinuesa JL, Bastos-GonźAlez D. Stability and physicochemical characteristics of PLGA, PLGA: Poloxamer and PLGA: Poloxamine blend nanoparticles. A comparative study. Colloids Surf A, 2007;296:132–40.
   Web of Science ®Google Scholar
• Scheithauera EC, Lia W, Dingb Y, Harhausc L, Roetherb JA, Boccaccinia AR. Preparation and characterization of electrosprayeddaidzein–loaded PHBV microspheres. Materials Lett, 2015;158:66–9.
   Web of Science ®Google Scholar
• Sepehri N, Rouhani H, Tavassolian F, Montazeri H, Khoshayand MR, Ghahremani MH, Ostad SN, Atyabi F, Dinarvand R. SN38 polymeric nanoparticles: In vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan. Int J Pharmaceutics, 2014;471:485–97.
   PubMed Web of Science ®Google Scholar
• Shoyele SA, Sivadas N, Cryan SA. The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation. AAPS Pharm Sci Tech, 2011;12:304–11.
   PubMed Web of Science ®Google Scholar
• Silva AL, Rosalia RA, Sazak A, Carstens MG, Ossendorp F, Oostendorp J, Jiskoot W. Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: Low-burst release is crucial for efficient CD8+ T cell activation. Eur J Pharm Biopharm, 2013;83:338–45.
   PubMed Web of Science ®Google Scholar
• Sinha V, Trehan A. Biodegradable microspheres for protein delivery. J Controll Release, 2003;90:261–80.
   PubMed Web of Science ®Google Scholar
• Vilos C, Constandil L, Herrera N, Solar P, Escobar-Fica J, Velasquez L. Ceftiofur-loaded PHBV microparticles: A potential formulation for a long-acting antibiotic to treat animal infections. Electron J Biotechnol, 2012;15:1–13s.
   Web of Science ®Google Scholar
• Vilos C, Morales FA, Solar PA, Herrera NS, Gonzalez-Nilo FD, Aguayo DA, Mendoza HL, Comer J, Bravo ML, Gonzalez PA, et al. Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary. Biomaterials, 2013;34:4098–108.
   PubMed Web of Science ®Google Scholar
• Vivian J, Callis P. Mechanisms of tryptophan fluorescence shifts in proteins. Biophys J, 2001;80:2093–109.
   PubMed Web of Science ®Google Scholar
• Vukomanovic M, Skapin SD, Jancar B, Maksin T, Ignjatovic N, Uskokovic V, Uskokovic D. Poly(D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres. Part 1: A multifunctional system for controlled drug delivery. Colloids Surf B Biointerfaces, 2011;82:404–13.
   PubMed Web of Science ®Google Scholar
• Wang F, Song YL, Li CX, Li DH, Zhang HP, Ma AJ, Xi XQ, Zhang N, Wang BG, Wang Y, Zhou W. Sustained release of insulin-like growth factor-1 from poly(lactide-co-glycolide) microspheres improves osseointegration of dental implants in type 2 diabetic rats. Eur J Pharmacol, 2010;640:226–32.
   PubMed Web of Science ®Google Scholar
• Wei G, Pettway GJ, Mccauley LK, Ma PX. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials, 2004;25:345–52.
   PubMed Web of Science ®Google Scholar
• Wei L, Mcdonald AG. Thermophysical properties of bacterial poly(3-hydroxybutyrate): Characterized by TMA, DSC and TMDSC. J Appl Polym Sci, 2015;132:10244–54.
   Web of Science ®Google Scholar
• Yan F, Zhang C, Zheng Y, Mei L, Tang L, Song C, Sun H, Huang L. The effect of poloxamer 188 on nanoparticle morphology, size, cancer cell uptake, and cytotoxicity. Nanomedicine, 2010;6:170–8.
   PubMed Web of Science ®Google Scholar
• Yanga YY, Chung TS, Ng NP. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials, 2001;22:231–41.
   PubMed Web of Science ®Google Scholar
• Yeo Y, Park K. Control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch Pharm Res., 2004;27:1–12.
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen D, Wang S, Zhu K. Optimizing double emulsion process to decrease the burst release of protein from biodegradable polymer microspheres. J Microencapsul, 2005;22:413–22.
   PubMed Web of Science ®Google Scholar
• Zheng C, Liang W. A one-step modified method to reduce the burst initial release from PLGA microspheres. Drug Deliv, 2010;17:77–82.
   PubMed Web of Science ®Google Scholar
• Zheng W. A water-in-oil-in-oil-in-water (W/O/O/W) method for producing drug-releasing, double-walled microspheres. Int J Pharmaceut, 2009;374:90–5.
   PubMed Web of Science ®Google Scholar
• Zhu XH, Wang CH, Tong YW. In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold. J Biomed Mater Res A, 2009;89:411–23.
   PubMed Web of Science ®Google Scholar